Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Cancer Metastatic|Hormone Receptor Positive Tumor|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|Ovarian Cancer|CCNE1 Amplification|Solid Tumor|Advanced Cancer|Metastatic Cancer
Interventions: DRUG: INX-315
Sponsor: Incyclix Bio